Medical Care
Global Neuroscience Antibodies and Assays Market Research Report 2025
- Sep 06, 25
- ID: 492107
- Pages: 89
- Figures: 86
- Views: 15
This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibodies and Assays, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibodies and Assays.
The Neuroscience Antibodies and Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroscience Antibodies and Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroscience Antibodies and Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens
Segment by Type
Consumables
Instruments
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Neuroscience Antibodies and Assays market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Neuroscience Antibodies and Assays market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Neuroscience Antibodies and Assays companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
Abcam
Bio-Rad
Merck
Cell Signaling Technology
Genscript
Rockland Immunochemicals
BioLegend
Santa Cruz Biotechnology
Roche
Siemens
Segment by Type
Consumables
Instruments
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Centers
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Neuroscience Antibodies and Assays company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Hospitals & Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Market Perspective (2020-2031)
2.2 Global Neuroscience Antibodies and Assays Growth Trends by Region
2.2.1 Global Neuroscience Antibodies and Assays Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neuroscience Antibodies and Assays Historic Market Size by Region (2020-2025)
2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Region (2026-2031)
2.3 Neuroscience Antibodies and Assays Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Industry Trends
2.3.2 Neuroscience Antibodies and Assays Market Drivers
2.3.3 Neuroscience Antibodies and Assays Market Challenges
2.3.4 Neuroscience Antibodies and Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2020-2025)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2020-2025)
3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neuroscience Antibodies and Assays Revenue
3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2024
3.5 Global Key Players of Neuroscience Antibodies and Assays Head office and Area Served
3.6 Global Key Players of Neuroscience Antibodies and Assays, Product and Application
3.7 Global Key Players of Neuroscience Antibodies and Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2020-2025)
4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2026-2031)
5 Neuroscience Antibodies and Assays Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2020-2025)
5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size (2020-2031)
6.2 North America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
6.4 North America Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size (2020-2031)
7.2 Europe Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
7.4 Europe Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2020-2031)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2020-2025)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Market Size (2020-2031)
9.2 Latin America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
9.4 Latin America Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2020-2031)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.1.5 Thermo Fisher Recent Development
11.2 Abcam
11.2.1 Abcam Company Details
11.2.2 Abcam Business Overview
11.2.3 Abcam Neuroscience Antibodies and Assays Introduction
11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.2.5 Abcam Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.3.5 Bio-Rad Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Neuroscience Antibodies and Assays Introduction
11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Cell Signaling Technology
11.5.1 Cell Signaling Technology Company Details
11.5.2 Cell Signaling Technology Business Overview
11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.5.5 Cell Signaling Technology Recent Development
11.6 Genscript
11.6.1 Genscript Company Details
11.6.2 Genscript Business Overview
11.6.3 Genscript Neuroscience Antibodies and Assays Introduction
11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.6.5 Genscript Recent Development
11.7 Rockland Immunochemicals
11.7.1 Rockland Immunochemicals Company Details
11.7.2 Rockland Immunochemicals Business Overview
11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.7.5 Rockland Immunochemicals Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Details
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.8.5 BioLegend Recent Development
11.9 Santa Cruz Biotechnology
11.9.1 Santa Cruz Biotechnology Company Details
11.9.2 Santa Cruz Biotechnology Business Overview
11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.9.5 Santa Cruz Biotechnology Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Neuroscience Antibodies and Assays Introduction
11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.10.5 Roche Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Neuroscience Antibodies and Assays Introduction
11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.11.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Consumables
1.2.3 Instruments
1.3 Market by Application
1.3.1 Global Neuroscience Antibodies and Assays Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Academic & Research Institutes
1.3.4 Hospitals & Diagnostic Centers
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Neuroscience Antibodies and Assays Market Perspective (2020-2031)
2.2 Global Neuroscience Antibodies and Assays Growth Trends by Region
2.2.1 Global Neuroscience Antibodies and Assays Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Neuroscience Antibodies and Assays Historic Market Size by Region (2020-2025)
2.2.3 Neuroscience Antibodies and Assays Forecasted Market Size by Region (2026-2031)
2.3 Neuroscience Antibodies and Assays Market Dynamics
2.3.1 Neuroscience Antibodies and Assays Industry Trends
2.3.2 Neuroscience Antibodies and Assays Market Drivers
2.3.3 Neuroscience Antibodies and Assays Market Challenges
2.3.4 Neuroscience Antibodies and Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neuroscience Antibodies and Assays Players by Revenue
3.1.1 Global Top Neuroscience Antibodies and Assays Players by Revenue (2020-2025)
3.1.2 Global Neuroscience Antibodies and Assays Revenue Market Share by Players (2020-2025)
3.2 Global Neuroscience Antibodies and Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Neuroscience Antibodies and Assays Revenue
3.4 Global Neuroscience Antibodies and Assays Market Concentration Ratio
3.4.1 Global Neuroscience Antibodies and Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroscience Antibodies and Assays Revenue in 2024
3.5 Global Key Players of Neuroscience Antibodies and Assays Head office and Area Served
3.6 Global Key Players of Neuroscience Antibodies and Assays, Product and Application
3.7 Global Key Players of Neuroscience Antibodies and Assays, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Neuroscience Antibodies and Assays Breakdown Data by Type
4.1 Global Neuroscience Antibodies and Assays Historic Market Size by Type (2020-2025)
4.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2026-2031)
5 Neuroscience Antibodies and Assays Breakdown Data by Application
5.1 Global Neuroscience Antibodies and Assays Historic Market Size by Application (2020-2025)
5.2 Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Neuroscience Antibodies and Assays Market Size (2020-2031)
6.2 North America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
6.4 North America Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Neuroscience Antibodies and Assays Market Size (2020-2031)
7.2 Europe Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
7.4 Europe Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neuroscience Antibodies and Assays Market Size (2020-2031)
8.2 Asia-Pacific Neuroscience Antibodies and Assays Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2020-2025)
8.4 Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Neuroscience Antibodies and Assays Market Size (2020-2031)
9.2 Latin America Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
9.4 Latin America Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neuroscience Antibodies and Assays Market Size (2020-2031)
10.2 Middle East & Africa Neuroscience Antibodies and Assays Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2020-2025)
10.4 Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Neuroscience Antibodies and Assays Introduction
11.1.4 Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.1.5 Thermo Fisher Recent Development
11.2 Abcam
11.2.1 Abcam Company Details
11.2.2 Abcam Business Overview
11.2.3 Abcam Neuroscience Antibodies and Assays Introduction
11.2.4 Abcam Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.2.5 Abcam Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Neuroscience Antibodies and Assays Introduction
11.3.4 Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.3.5 Bio-Rad Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Neuroscience Antibodies and Assays Introduction
11.4.4 Merck Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Cell Signaling Technology
11.5.1 Cell Signaling Technology Company Details
11.5.2 Cell Signaling Technology Business Overview
11.5.3 Cell Signaling Technology Neuroscience Antibodies and Assays Introduction
11.5.4 Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.5.5 Cell Signaling Technology Recent Development
11.6 Genscript
11.6.1 Genscript Company Details
11.6.2 Genscript Business Overview
11.6.3 Genscript Neuroscience Antibodies and Assays Introduction
11.6.4 Genscript Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.6.5 Genscript Recent Development
11.7 Rockland Immunochemicals
11.7.1 Rockland Immunochemicals Company Details
11.7.2 Rockland Immunochemicals Business Overview
11.7.3 Rockland Immunochemicals Neuroscience Antibodies and Assays Introduction
11.7.4 Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.7.5 Rockland Immunochemicals Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Details
11.8.2 BioLegend Business Overview
11.8.3 BioLegend Neuroscience Antibodies and Assays Introduction
11.8.4 BioLegend Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.8.5 BioLegend Recent Development
11.9 Santa Cruz Biotechnology
11.9.1 Santa Cruz Biotechnology Company Details
11.9.2 Santa Cruz Biotechnology Business Overview
11.9.3 Santa Cruz Biotechnology Neuroscience Antibodies and Assays Introduction
11.9.4 Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.9.5 Santa Cruz Biotechnology Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Neuroscience Antibodies and Assays Introduction
11.10.4 Roche Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.10.5 Roche Recent Development
11.11 Siemens
11.11.1 Siemens Company Details
11.11.2 Siemens Business Overview
11.11.3 Siemens Neuroscience Antibodies and Assays Introduction
11.11.4 Siemens Revenue in Neuroscience Antibodies and Assays Business (2020-2025)
11.11.5 Siemens Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Consumables
Table 3. Key Players of Instruments
Table 4. Global Neuroscience Antibodies and Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Neuroscience Antibodies and Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Neuroscience Antibodies and Assays Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Neuroscience Antibodies and Assays Market Share by Region (2020-2025)
Table 8. Global Neuroscience Antibodies and Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Neuroscience Antibodies and Assays Market Share by Region (2026-2031)
Table 10. Neuroscience Antibodies and Assays Market Trends
Table 11. Neuroscience Antibodies and Assays Market Drivers
Table 12. Neuroscience Antibodies and Assays Market Challenges
Table 13. Neuroscience Antibodies and Assays Market Restraints
Table 14. Global Neuroscience Antibodies and Assays Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Neuroscience Antibodies and Assays Market Share by Players (2020-2025)
Table 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2024)
Table 17. Ranking of Global Top Neuroscience Antibodies and Assays Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Neuroscience Antibodies and Assays, Headquarters and Area Served
Table 20. Global Key Players of Neuroscience Antibodies and Assays, Product and Application
Table 21. Global Key Players of Neuroscience Antibodies and Assays, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuroscience Antibodies and Assays Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2020-2025)
Table 25. Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2026-2031)
Table 27. Global Neuroscience Antibodies and Assays Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2020-2025)
Table 29. Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2026-2031)
Table 31. North America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Neuroscience Antibodies and Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 46. Thermo Fisher Company Details
Table 47. Thermo Fisher Business Overview
Table 48. Thermo Fisher Neuroscience Antibodies and Assays Product
Table 49. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 50. Thermo Fisher Recent Development
Table 51. Abcam Company Details
Table 52. Abcam Business Overview
Table 53. Abcam Neuroscience Antibodies and Assays Product
Table 54. Abcam Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 55. Abcam Recent Development
Table 56. Bio-Rad Company Details
Table 57. Bio-Rad Business Overview
Table 58. Bio-Rad Neuroscience Antibodies and Assays Product
Table 59. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 60. Bio-Rad Recent Development
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Neuroscience Antibodies and Assays Product
Table 64. Merck Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Cell Signaling Technology Company Details
Table 67. Cell Signaling Technology Business Overview
Table 68. Cell Signaling Technology Neuroscience Antibodies and Assays Product
Table 69. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 70. Cell Signaling Technology Recent Development
Table 71. Genscript Company Details
Table 72. Genscript Business Overview
Table 73. Genscript Neuroscience Antibodies and Assays Product
Table 74. Genscript Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 75. Genscript Recent Development
Table 76. Rockland Immunochemicals Company Details
Table 77. Rockland Immunochemicals Business Overview
Table 78. Rockland Immunochemicals Neuroscience Antibodies and Assays Product
Table 79. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 80. Rockland Immunochemicals Recent Development
Table 81. BioLegend Company Details
Table 82. BioLegend Business Overview
Table 83. BioLegend Neuroscience Antibodies and Assays Product
Table 84. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 85. BioLegend Recent Development
Table 86. Santa Cruz Biotechnology Company Details
Table 87. Santa Cruz Biotechnology Business Overview
Table 88. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product
Table 89. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 90. Santa Cruz Biotechnology Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Neuroscience Antibodies and Assays Product
Table 94. Roche Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Siemens Company Details
Table 97. Siemens Business Overview
Table 98. Siemens Neuroscience Antibodies and Assays Product
Table 99. Siemens Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 100. Siemens Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Neuroscience Antibodies and Assays Picture
Figure 2. Global Neuroscience Antibodies and Assays Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuroscience Antibodies and Assays Market Share by Type: 2024 VS 2031
Figure 4. Consumables Features
Figure 5. Instruments Features
Figure 6. Global Neuroscience Antibodies and Assays Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Neuroscience Antibodies and Assays Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Academic & Research Institutes Case Studies
Figure 10. Hospitals & Diagnostic Centers Case Studies
Figure 11. Neuroscience Antibodies and Assays Report Years Considered
Figure 12. Global Neuroscience Antibodies and Assays Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Neuroscience Antibodies and Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Neuroscience Antibodies and Assays Market Share by Region: 2024 VS 2031
Figure 15. Global Neuroscience Antibodies and Assays Market Share by Players in 2024
Figure 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2024
Figure 18. North America Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 20. United States Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 24. Germany Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Region (2020-2031)
Figure 32. China Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 40. Mexico Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 44. Turkey Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Thermo Fisher Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 48. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 49. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 51. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 52. Genscript Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 53. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 54. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 55. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 56. Roche Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 57. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Neuroscience Antibodies and Assays Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Consumables
Table 3. Key Players of Instruments
Table 4. Global Neuroscience Antibodies and Assays Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Neuroscience Antibodies and Assays Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Neuroscience Antibodies and Assays Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Neuroscience Antibodies and Assays Market Share by Region (2020-2025)
Table 8. Global Neuroscience Antibodies and Assays Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Neuroscience Antibodies and Assays Market Share by Region (2026-2031)
Table 10. Neuroscience Antibodies and Assays Market Trends
Table 11. Neuroscience Antibodies and Assays Market Drivers
Table 12. Neuroscience Antibodies and Assays Market Challenges
Table 13. Neuroscience Antibodies and Assays Market Restraints
Table 14. Global Neuroscience Antibodies and Assays Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Neuroscience Antibodies and Assays Market Share by Players (2020-2025)
Table 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2024)
Table 17. Ranking of Global Top Neuroscience Antibodies and Assays Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Neuroscience Antibodies and Assays Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Neuroscience Antibodies and Assays, Headquarters and Area Served
Table 20. Global Key Players of Neuroscience Antibodies and Assays, Product and Application
Table 21. Global Key Players of Neuroscience Antibodies and Assays, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Neuroscience Antibodies and Assays Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2020-2025)
Table 25. Global Neuroscience Antibodies and Assays Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Neuroscience Antibodies and Assays Revenue Market Share by Type (2026-2031)
Table 27. Global Neuroscience Antibodies and Assays Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2020-2025)
Table 29. Global Neuroscience Antibodies and Assays Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Neuroscience Antibodies and Assays Revenue Market Share by Application (2026-2031)
Table 31. North America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Neuroscience Antibodies and Assays Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Neuroscience Antibodies and Assays Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Neuroscience Antibodies and Assays Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Neuroscience Antibodies and Assays Market Size by Country (2026-2031) & (US$ Million)
Table 46. Thermo Fisher Company Details
Table 47. Thermo Fisher Business Overview
Table 48. Thermo Fisher Neuroscience Antibodies and Assays Product
Table 49. Thermo Fisher Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 50. Thermo Fisher Recent Development
Table 51. Abcam Company Details
Table 52. Abcam Business Overview
Table 53. Abcam Neuroscience Antibodies and Assays Product
Table 54. Abcam Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 55. Abcam Recent Development
Table 56. Bio-Rad Company Details
Table 57. Bio-Rad Business Overview
Table 58. Bio-Rad Neuroscience Antibodies and Assays Product
Table 59. Bio-Rad Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 60. Bio-Rad Recent Development
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Neuroscience Antibodies and Assays Product
Table 64. Merck Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Cell Signaling Technology Company Details
Table 67. Cell Signaling Technology Business Overview
Table 68. Cell Signaling Technology Neuroscience Antibodies and Assays Product
Table 69. Cell Signaling Technology Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 70. Cell Signaling Technology Recent Development
Table 71. Genscript Company Details
Table 72. Genscript Business Overview
Table 73. Genscript Neuroscience Antibodies and Assays Product
Table 74. Genscript Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 75. Genscript Recent Development
Table 76. Rockland Immunochemicals Company Details
Table 77. Rockland Immunochemicals Business Overview
Table 78. Rockland Immunochemicals Neuroscience Antibodies and Assays Product
Table 79. Rockland Immunochemicals Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 80. Rockland Immunochemicals Recent Development
Table 81. BioLegend Company Details
Table 82. BioLegend Business Overview
Table 83. BioLegend Neuroscience Antibodies and Assays Product
Table 84. BioLegend Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 85. BioLegend Recent Development
Table 86. Santa Cruz Biotechnology Company Details
Table 87. Santa Cruz Biotechnology Business Overview
Table 88. Santa Cruz Biotechnology Neuroscience Antibodies and Assays Product
Table 89. Santa Cruz Biotechnology Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 90. Santa Cruz Biotechnology Recent Development
Table 91. Roche Company Details
Table 92. Roche Business Overview
Table 93. Roche Neuroscience Antibodies and Assays Product
Table 94. Roche Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 95. Roche Recent Development
Table 96. Siemens Company Details
Table 97. Siemens Business Overview
Table 98. Siemens Neuroscience Antibodies and Assays Product
Table 99. Siemens Revenue in Neuroscience Antibodies and Assays Business (2020-2025) & (US$ Million)
Table 100. Siemens Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Neuroscience Antibodies and Assays Picture
Figure 2. Global Neuroscience Antibodies and Assays Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Neuroscience Antibodies and Assays Market Share by Type: 2024 VS 2031
Figure 4. Consumables Features
Figure 5. Instruments Features
Figure 6. Global Neuroscience Antibodies and Assays Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Neuroscience Antibodies and Assays Market Share by Application: 2024 VS 2031
Figure 8. Pharmaceutical & Biotechnology Companies Case Studies
Figure 9. Academic & Research Institutes Case Studies
Figure 10. Hospitals & Diagnostic Centers Case Studies
Figure 11. Neuroscience Antibodies and Assays Report Years Considered
Figure 12. Global Neuroscience Antibodies and Assays Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Neuroscience Antibodies and Assays Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Neuroscience Antibodies and Assays Market Share by Region: 2024 VS 2031
Figure 15. Global Neuroscience Antibodies and Assays Market Share by Players in 2024
Figure 16. Global Top Neuroscience Antibodies and Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibodies and Assays as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Neuroscience Antibodies and Assays Revenue in 2024
Figure 18. North America Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 20. United States Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 24. Germany Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Neuroscience Antibodies and Assays Market Share by Region (2020-2031)
Figure 32. China Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 40. Mexico Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Neuroscience Antibodies and Assays Market Share by Country (2020-2031)
Figure 44. Turkey Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Neuroscience Antibodies and Assays Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Thermo Fisher Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 48. Abcam Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 49. Bio-Rad Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 50. Merck Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 51. Cell Signaling Technology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 52. Genscript Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 53. Rockland Immunochemicals Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 54. BioLegend Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 55. Santa Cruz Biotechnology Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 56. Roche Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 57. Siemens Revenue Growth Rate in Neuroscience Antibodies and Assays Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Ethylene Oxide (EO) Market Research Report 2026
Jan 17, 26
Global Stem Cells Cryopreservation Equipments Market Research Report 2026
Jan 17, 26
Global Selenium-enriched Yeast Market Research Report 2026
Jan 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232